Hyperprolactinaemia
This article needs more primary sources. (May 2017) |
Hyperprolactinaemia | |
---|---|
Other names | Hyperprolactinemia |
Prolactin | |
Specialty | Endocrinology |
Hyperprolactinaemia is the presence of abnormally high levels of
Although hyperprolactinemia can result from normal physiological changes during pregnancy and breastfeeding, it can also be caused by other etiologies. For example, high prolactin levels could result from diseases affecting the hypothalamus and pituitary gland.[2] Other organs, such as the liver and kidneys, could affect prolactin clearance and consequently, prolactin levels in the serum.[2] The disruption of prolactin regulation could also be attributed to external sources such as medications.[2]
In the general population, the prevalence of hyperprolactinemia is 0.4%.
Signs and symptoms
In women, high blood levels of prolactin are typically associated with hypoestrogenism, anovulatory infertility, and changes in menstruation.[6][7] Menstruation disturbances experienced in women commonly manifests as amenorrhea or oligomenorrhea. In the latter case, irregular menstrual flow may result in abnormally heavy and prolonged bleeding (menorrhagia).[1] Women who are not pregnant or nursing may also unexpectedly begin producing breast milk (galactorrhea), a condition that is not always associated with high prolactin levels. For instance, many premenopausal women experiencing hyperprolactinemia do not experience galactorrhea and only some women who experience galactorrhea will be diagnosed with hyperprolactinemia. Thus, galactorrhea may be observed in individuals with normal prolactin levels and does not necessarily indicate hyperprolactinemia.[8] This phenomenon is likely due to galactorrhea requiring adequate levels of progesterone or estrogen to prepare the breast tissue. Additionally, some women may also experience loss of libido and breast pain, particularly when prolactin levels rise initially, as the hormone promotes tissue changes in the breast.[2]
In men, the most common symptoms of hyperprolactinemia are decreased
Long-term hyperprolactinaemia can lead to detrimental changes in bone metabolism as a result of
Causes
Prolactin secretion is regulated by both stimulatory and inhibitory mechanisms.[3] Dopamine acts on pituitary lactotroph D2 receptors to inhibit prolactin secretion while other peptides and hormones, such as thyrotropin releasing hormone (TRH), stimulate prolactin secretion.[3] As a result, hyperprolactinemia may be caused by disinhibition (e.g., compression of the pituitary stalk or reduced dopamine levels) or excess production.[3] The most common cause of hyperprolactinemia is prolactinoma (a type of pituitary adenoma).[3] A blood serum prolactin level of 1000–5000 mIU/L (47–235 ng/mL) may arise from either mechanism, however levels >5000 mIU/L (>235 ng/mL) is likely due to the activity of an adenoma. Prolactin blood levels are typically correlated to the size the tumors. Pituitary tumors smaller than 10 mm in diameter, or microadenomas, tend to have prolactin levels <200 ng/mL. Macroadenomas larger than 10 mm in diameter possess prolactin >1000 ng/mL.[13]
Hyperprolactinemia inhibits the secretion of gonadotropin-releasing hormone (GnRH) from the hypothalamus, which in turn inhibits the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland and results in diminished gonadal sex hormone production (termed hypogonadism).[14] This is the cause of many of the symptoms described below.
In many people, elevated prolactin levels remain unexplained and may represent a form of hypothalamic–pituitary–adrenal axis dysregulation.[15]
Causes of hyperprolactinemia[3] | |
---|---|
Physiologic hypersecretion |
|
Hypothalamic-pituitary stalk damage |
|
Pituitary hypersecretion | |
Systemic disorders |
|
Drug-induced hypersecretion |
|
Physiological causes
Physiological (i.e., non-
Medications
Prolactin secretion in the pituitary is normally suppressed by the brain chemical
Specific diseases
Prolactinoma or other tumors arising in or near the pituitary—such as those that cause
Nonpuerperal mastitis may induce transient hyperprolactinemia (neurogenic hyperprolactinemia) of about three weeks' duration; conversely, hyperprolactinemia may contribute to nonpuerperal mastitis.[23]
Apart from diagnosing hyperprolactinemia and
Diagnosis
An appropriate diagnosis of hyperprolactinemia starts with conducting a complete clinical history before performing any treatment. Physiological causes, systemic disorders, and the use of certain drugs must be ruled out before the condition is diagnosed. Screening is indicated for those who are asymptomatic and those with elevated prolactin without an associated cause.
The most common causes of hyperprolactinemia are prolactinomas, drug-induced hyperprolactinemia, and macroprolactinemia. Individuals with hyperprolactinemia may present with symptoms including galactorrhea, hypogonadism effects, and/or infertility. The magnitude that prolactin is elevated can be used as an indicator of the etiology of the hyperprolactinemia diagnosis. Prolactin levels over 250 ng/mL may suggest prolactinoma. Prolactin levels less than 100 ng/mL may suggest drug-induced hyperprolactinemia, macroprolactinemia, nonfunctioning pituitary adenomas, or systemic disorders.[25][14]
Elevated prolactin blood levels are typically assessed in women with unexplained breast milk secretion (
However, a high measurement of prolactin may also result from the presence of
Treatment
Treatment for hyperprolactinemia is usually dependent upon its cause, ranging from hypothyroidism, drug-induced hyperprolactinemia, hypothalamic disease, idiopathic hyperprolactinemia, macroprolactin, or prolactinoma. Therefore, in order to provide the proper management of hyperprolactinemia, the pathological form and physiological increase in prolactin levels are differentiated, and the correct cause of hyperprolactinemia must be identified before treatment. For functional asymptomatic hyperprolactinemia, the treatment of choice is removing the associated cause, including antipsychotic therapy. However, prolactin levels should be drawn and monitored both prior to any discontinuation or changes to therapy, and afterwards. With symptomatic hyperprolactinemia, stopping antipsychotic drugs for a short trial period are not recommended due to the risk of exacerbation or relapse of symptoms. Options for treatment include decreasing the dose of antipsychotics, adding aripiprazole as an adjunctive therapy, and switching antipsychotics as a last resort.[4] In pharmacologic hyperprolactinemia, the concerning drug can be switched to another treatment or discontinued entirely.[29] Vitex agnus-castus extract may be tried in cases of mild hyperprolactinemia.[30] No treatment is required in asymptomatic macroprolactin and instead, serial prolactin measurements and pituitary imaging is monitored in a regular follow-up appointments.[16]
Medical therapy is the preferred treatment in prolactinomas.[3] In most cases, medications that are dopamine agonists, such as cabergoline[31] and bromocriptine (often preferred when pregnancy is possible), are the treatment of choice used to decrease prolactin levels and tumor size upon the presence of microadenomas or macroadenomas.[1][32][33] A systematic review and meta-analyses has shown that cabergoline is more effective in treatment of hyperprolactinemia than bromocriptine.[34] Other dopamine agonists that have been used less commonly to suppress prolactin include dihydroergocryptine, ergoloid, lisuride, metergoline, pergolide, quinagolide, and terguride.[35][36] If the prolactinoma does not initially respond to dopamine agonist therapy, such that prolactin levels are still high or the tumor is not shrinking as expected, the dose of the dopamine agonist can be increased in a stepwise fashion to the maximum tolerated dose.[3] Another option is to consider switching between dopamine agonists. It is possible for the prolactinoma to be resistant to bromocriptine but respond well to cabergoline and vice versa.[3] Surgical therapy can be considered if pharmacologic options have been exhausted.[3]
There is evidence to support improvement in outcomes of hyperprolactinemic individuals who have shown to be resistant to or intolerant of the treatment of choice, dopamine agonists, through radiotherapy and surgery.[34]
See also
References
- ^ PMID 30726016, retrieved 2021-07-27
- ^ PMID 24347930.
- ^ PMID 21296991.
- ^ PMID 31847209.
- PMID 23968123.
- S2CID 211063583.
- S2CID 23642551.
- S2CID 2846310.
- S2CID 24140780.
- ^ S2CID 34712756.
- S2CID 214647438.
- S2CID 22543496.
- PMID 29083585, retrieved 2021-07-30
- ^ PMID 30889571.
- PMID 16202380.
- ^ S2CID 28930221. Retrieved 2021-07-26.
- PMID 30627169.
- S2CID 221202364.
- PMID 21221191.
- PMID 18473017.
- S2CID 40784598.
- S2CID 22718652.
- PMID 2918655.
- S2CID 227156239.
- PMID 26820213.
- ^ PMID 31523136.
- S2CID 53039562.
- PMID 22029027.
- PMID 25732643.
- S2CID 38664195.
- PMID 10404830.
- S2CID 41767167.
- S2CID 21104519.
- ^ PMID 22828169.
- S2CID 31677949.
- S2CID 29368668.